Skip to main content

Month: March 2025

Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt Transaction Update

Four new funding proposals, totalling US$117.5 million, have been submitted for reviewModifications received to U.S. Air Force Academy Cooperative AgreementOutside date for going-private transaction extended to March 31, 2025 HALIFAX, Nova Scotia, March 18, 2025 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced that, the Company along with its partners, have submitted applications for four new federal funding opportunities. The funding, if awarded, would total up to US$117.5 million and support the company’s efforts to advance urgent infectious disease treatments aligned with critical public health priorities. Funding Opportunities By leveraging Appili’s...

Continue reading

Massachusetts Department of Transportation Selects Draganfly for Drone Medical Delivery Demonstration and Reports Its Successful Completion

Boston, MA., March 18, 2025 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is excited to announce it was selected by Massachusetts Department of Transportation (MassDOT) Aeronautics Division for and, successfully completed a demonstration for the simulated delivery of medical supplies for use in support of home-based healthcare. The medical delivery demonstrations took place between August and October 2024 and involved three selected companies, including Draganfly. “This medical delivery demonstration underscores the value of drones for many operational needs,” said Transportation Secretary and CEO Monica Tibbits-Nutt, “Drones already have proven useful with operations, including MBTA track corridor...

Continue reading

Rygte i Inside Business

Under henvisning til dagens artikel i Inside Business kan det bekræftes, at der har været rettet henvendelse til bestyrelsesformanden for PARKEN Sport & Entertainment A/S (”PSE”) vedrørende muligheden for en dialog med PSEs storaktionærer om et muligt bud på selskabet. Henvendelsen blev vurderet som uinteressant, og blev afvist i umiddelbar forlængelse af modtagelsen. Der har på denne baggrund ikke været nogen dialog med PSE eller PSEs storaktionærer. Med venlig hilsenPARKEN Sport & Entertainment A/S Henrik Møgelmose BestyrelsesformandAttachment06-2025 Rygte i Inside Business

Continue reading

REGO’s Recent Momentum Positions the Company as a Premier White-Labeled Family Lifecycle Financial Solutions Platform for Banks and Credit Unions

With market traction, product innovation, and an industry-leading advisory board, REGO continues its mission to help financial institutions bank the entire family, from youth to seniors BLUE BELL, Pa., March 18, 2025 (GLOBE NEWSWIRE) — Rego Payment Architectures, Inc. (“REGO”) (OTCQB: RPMT), provider of a leading white-labeled family financial lifecycle solutions platform, announces significant corporate achievements including market expansion, product innovation, and the continued growth of its executive leadership and advisory board. With adoption of its youth banking product and recent launch of its senior financial management (SFM) solutions, REGO is providing tools to transform how banks and credit unions serve families across multiple generations. Building the Leading Family Lifecycle Banking Platform Since 2020, REGO has...

Continue reading

ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®

BAUDETTE, Minn., March 18, 2025 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that it has completed the buyout of its 3.125% perpetual royalty obligation to SWK Funding LLC (SWK) on worldwide net revenues of ILUVIEN and YUTIQ for a one-time payment of $17.25 million. Under the terms of the agreement, upon making the buyout payment, no further royalty is due to SWK on net revenues beginning January 1, 2025, forward. ANI funded the buyout with cash on hand. Nikhil Lalwani, President and CEO of ANI stated, “This transaction reflects our commitment to strengthening our Retina portfolio and maximizing the long-term value of ILUVIEN and YUTIQ. By eliminating this royalty obligation, we have enhanced our financial flexibility and ability to accelerate growth as we pursue our purpose of...

Continue reading

Critical One Announces Appointment of Award-Winning Geologist to Board of Directors

Chet Idziszek, Former Chief Geologist of Howells Lake Antimony Gold Project, Joins Team as Independent Director TORONTO, March 18, 2025 (GLOBE NEWSWIRE) — Critical One Energy Inc. (formerly Madison Metals Inc.) (“Critical One” or the “Company”) (CSE: CRTL) (OTCQB: MMTLF) (FSE: 4EF0) announces the appointment of Chet Idziszek as an independent Board member, effective immediately. “We are pleased to welcome Chet Idziszek to our team,” said Duane Parnham, Executive Chairman and CEO of Critical One. “Chet has deep experience and insight regarding our Howells Lake Antimony Gold Project as the former chief geologist overseeing all aspects of the exploration. He will be invaluable as we grow our business and pursue the development of this unique project with significant historical resources.” Mr. Idziszek holds a Master of Applied Sciences...

Continue reading

Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

Management to Hold Investor Day Conference Call Today at 10:00am ETReported record product revenue of $11.6 million in Q4 2024, an increase of 59% over Q4 2023, representing the 16th straight quarter of sequential product sales growth Closed the transformational acquisition of pediatric endocrinology biologic Increlex® and relaunched the product in January Acquired and relaunched ultra rare disease product Galzin® Licensed U.S. rights to late-stage pipeline candidate Amglidia®, further boosting the Company’s pediatric endocrinology pipeline Announced positive pivotal clinical study results for ET-600; preparing for an April 2025 NDA submission Manufactured ET-400 launch inventory in preparation for a potential approval on its PDUFA goal date of May 28 Management to hold Investor Day conference call today at 10:00am ET to discuss its...

Continue reading

Edmiston Drive Capital Corp. Announces LOI with Canada Nickel Company

VANCOUVER, British Columbia, March 18, 2025 (GLOBE NEWSWIRE) — Edmiston Drive Capital Corp. (“EDCC” or the “Company“) is pleased to announce that it has entered into a letter of intent effective March 17, 2025 (the “LOI“) setting out the terms of a proposed business combination (the “Transaction“) with a wholly-owned subsidiary of Canada Nickel Company (“CNC“). Under the terms of the LOI, Canada Nickel will grant net smelter return royalty interests on all of its regional exploration properties in the Timmins District (excluding the Crawford Project and the Dargavel and Kingsmill targets located on the original Project 81 patents) to a wholly-owned subsidiary (“RoyaltyCo“), and RoyaltyCo will amalgamate with a wholly-owned subsidiary of EDCC in exchange for...

Continue reading

KE Holdings Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results and a Final Cash Dividend

BEIJING, March 18, 2025 (GLOBE NEWSWIRE) — KE Holdings Inc. (“Beike” or the “Company”) (NYSE: BEKE and HKEX: 2423), a leading integrated online and offline platform for housing transactions and services, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024, and also announced a final cash dividend. Business and Financial Highlights for the Fourth Quarter and Fiscal Year 2024Gross transaction value (GTV)1 in 2024 was RMB3,349.4 billion (US$458.9 billion), an increase of 6.6% year-over-year. GTV of existing home transactions was RMB2,246.5 billion (US$307.8 billion), an increase of 10.8% year-over-year. GTV of new home transactions was RMB970.0 billion (US$132.9 billion), a decrease of 3.3% year-over-year. GTV of home renovation and furnishing was RMB16.9 billion (US$2.3...

Continue reading

XPENG Reports Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

Cash and cash equivalents, restricted cash, short-term investments and time deposits were RMB41.96 billion (US$5.75 billion) as of December 31, 2024 Quarterly total revenues were RMB16.11 billion, a 59.4% increase quarter-over-quarter Quarterly gross margin was 14.4%, an increase of 8.2 percentage points over the same period of 2023 Quarterly vehicle margin was 10.0%, an increase of 5.9 percentage points over the same period of 2023 Full year vehicle deliveries reached 190,068, a 34.2% increase year-over-year Full year revenues reached RMB40.87 billion, a 33.2% increase year-over-year Full year gross margin was 14.3%, an increase of 12.8 percentage points year-over-yearGUANGZHOU, China, March 18, 2025 (GLOBE NEWSWIRE) — XPeng Inc. (“XPENG” or the “Company,” NYSE: XPEV and HKEX: 9868), a leading Chinese smart electric vehicle...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.